Dr. Hiroko Kunitake, MD

Dr. Kunitake practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Kunitake's NPI, 1043346786, was assigned on February 26, 2007. Dr. Kunitake graduated from University of California, Geffen School of Medicine in 2005. Dr. Kunitake holds Massachusetts license 254834.

Dr. Kunitake's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Kunitake's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Kunitake is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Kunitake to 3 more hospitals, 2 group practices and clinics, 1 community health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kunitake practices, 8 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Kunitake's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Kunitake is licensed in Massachusetts.

CMS data shows 342 Medicare services from Dr. Kunitake across 9 procedure codes in 2024, for 214 Medicare patients. Medicare paid $35,831 for them.

CMS counts 214 Medicare patients who saw Dr. Kunitake in 2024. The largest group is 65 to 74, with 95 patients. 71% of them have high blood pressure, and 68% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kunitake's median patient age at 64, with 61% women.

In 2024, Dr. Kunitake wrote 106 Medicare Part D claims for 41 patients. 95% of them were for generic drugs. CMS names the drug for 83 of them, across 3 drugs with 11 or more claims each, at $382 in total drug cost. In 2023, CMS named 69 claims across 3 drugs.

Dr. Kunitake accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kunitake as offering telehealth. CMS counts 34 procedures of colonoscopy by Dr. Kunitake, more than 56% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 86 papers to Dr. Kunitake, published from 2010 to 2025. 2018 was the busiest year, with 9. The most frequent topics are Rectal Neoplasms, Postoperative Complications and Colonic Neoplasms. Dr. Kunitake has published most often in Dis Colon Rectum. Dr. Kunitake's most frequent co-authors are David L. Berger, MD, Rocco Ricciardi, MD and Liliana G. Bordeianou, MD.

Dmand AI links Dr. Kunitake to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Crohn Disease and Inflammatory Bowel Diseases.

CMS Open Payments shows 24 general payments to Dr. Kunitake from 2 drug and device companies from 2016 to 2023. Education make up the largest share, 75% of the total. Intuitive Surgical, Inc. paid the most, $12,631.

Dr. Kunitake graduated from University of California, Geffen School of Medicine in 2005.